questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Hémoprotéines
Globines
Hémoglobines
Hémoglobines anormales
Hémoglobine C
Hémoglobine C : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hémoglobine C
Électrophorèse de l'hémoglobine
Hémoglobine C
Tests de laboratoire
Dépistage néonatal
Hémoglobine C
Symptômes
5
Complications
Hémoglobine C
Prévention
5
Complications
Hémoglobine C
Conseils génétiques
Hémoglobine C
Vaccination
Hémoglobine C
Traitements
5
Transfusion sanguine
Hémoglobine C
Hydroxyurée
Hémoglobine C
Thérapie génique
Hémoglobine C
Analgésiques
Hémoglobine C
Complications
5
Complications
Hémoglobine C
Crise vaso-occlusive
Hémoglobine C
Problèmes hépatiques
Hémoglobine C
Surveillance
Hémoglobine C
Facteurs de risque
5
Facteurs de risque
Hémoglobine C
Origine ethnique
Hémoglobine C
Antécédents familiaux
Hémoglobine C
Mode de vie
Hémoglobine C
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hémoglobine C : Questions médicales les plus fréquentes",
"headline": "Hémoglobine C : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hémoglobine C : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-16",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hémoglobine C"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hémoglobines anormales",
"url": "https://questionsmedicales.fr/mesh/D006455",
"about": {
"@type": "MedicalCondition",
"name": "Hémoglobines anormales",
"code": {
"@type": "MedicalCode",
"code": "D006455",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.316.762.426"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hémoglobine C",
"alternateName": "Hemoglobin C",
"code": {
"@type": "MedicalCode",
"code": "D006444",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mei Zhang",
"url": "https://questionsmedicales.fr/author/Mei%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China."
}
},
{
"@type": "Person",
"name": "Benjamin Fröhlich",
"url": "https://questionsmedicales.fr/author/Benjamin%20Fr%C3%B6hlich",
"affiliation": {
"@type": "Organization",
"name": "1Physical Chemistry of Biosystems, Heidelberg University, Im Neuenheimer Feld 253, 69120 Heidelberg, Germany."
}
},
{
"@type": "Person",
"name": "Christine Lansche",
"url": "https://questionsmedicales.fr/author/Christine%20Lansche",
"affiliation": {
"@type": "Organization",
"name": "3Department of Infectious Diseases, Parasitology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany."
}
},
{
"@type": "Person",
"name": "Michael Lanzer",
"url": "https://questionsmedicales.fr/author/Michael%20Lanzer",
"affiliation": {
"@type": "Organization",
"name": "3Department of Infectious Diseases, Parasitology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany."
}
},
{
"@type": "Person",
"name": "Motomu Tanaka",
"url": "https://questionsmedicales.fr/author/Motomu%20Tanaka",
"affiliation": {
"@type": "Organization",
"name": "1Physical Chemistry of Biosystems, Heidelberg University, Im Neuenheimer Feld 253, 69120 Heidelberg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/36068430",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40264-022-01216-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ferric Carboxymaltose in Heart Failure with Iron Deficiency.",
"datePublished": "2023-08-26",
"url": "https://questionsmedicales.fr/article/37632463",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1056/NEJMoa2304968"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ferric Pyrophosphate Forms Soluble Iron Coordination Complexes with Zinc Compounds and Solubilizing Agents in Extruded Rice and Predicts Increased Iron Solubility and Bioavailability in Young Women.",
"datePublished": "2022-12-24",
"url": "https://questionsmedicales.fr/article/36931746",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tjnut.2022.12.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Systematic Review, Meta-Analysis, and Indirect Comparison of Blindly Adjudicated Cardiovascular Event Incidence with Ferric Derisomaltose, Ferric Carboxymaltose, and Iron Sucrose.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35947351",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12325-022-02242-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35790696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12185-022-03401-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hémoprotéines",
"item": "https://questionsmedicales.fr/mesh/D006420"
},
{
"@type": "ListItem",
"position": 5,
"name": "Globines",
"item": "https://questionsmedicales.fr/mesh/D005914"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hémoglobines",
"item": "https://questionsmedicales.fr/mesh/D006454"
},
{
"@type": "ListItem",
"position": 7,
"name": "Hémoglobines anormales",
"item": "https://questionsmedicales.fr/mesh/D006455"
},
{
"@type": "ListItem",
"position": 8,
"name": "Hémoglobine C",
"item": "https://questionsmedicales.fr/mesh/D006444"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hémoglobine C - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hémoglobine C",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hémoglobine C",
"description": "Comment diagnostiquer l'hémoglobine C ?\nQuels tests sont utilisés pour l'hémoglobine C ?\nL'hémoglobine C est-elle héréditaire ?\nQuels symptômes indiquent un test pour l'hémoglobine C ?\nPeut-on détecter l'hémoglobine C à la naissance ?",
"url": "https://questionsmedicales.fr/mesh/D006444?mesh_terms=Ferric+Compounds#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hémoglobine C",
"description": "Quels sont les symptômes de l'hémoglobine C ?\nL'hémoglobine C cause-t-elle de l'anémie ?\nY a-t-il des complications liées à l'hémoglobine C ?\nLes symptômes varient-ils selon l'âge ?\nL'hémoglobine C provoque-t-elle des douleurs ?",
"url": "https://questionsmedicales.fr/mesh/D006444?mesh_terms=Ferric+Compounds#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hémoglobine C",
"description": "Peut-on prévenir l'hémoglobine C ?\nLe dépistage est-il recommandé ?\nComment éviter les complications ?\nLes conseils génétiques sont-ils utiles ?\nY a-t-il des vaccinations recommandées ?",
"url": "https://questionsmedicales.fr/mesh/D006444?mesh_terms=Ferric+Compounds#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hémoglobine C",
"description": "Comment traite-t-on l'hémoglobine C ?\nLes transfusions sont-elles nécessaires ?\nY a-t-il des médicaments spécifiques pour l'hémoglobine C ?\nLa thérapie génique est-elle une option ?\nComment gérer les crises douloureuses ?",
"url": "https://questionsmedicales.fr/mesh/D006444?mesh_terms=Ferric+Compounds#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hémoglobine C",
"description": "Quelles sont les complications possibles ?\nL'hémoglobine C augmente-t-elle le risque d'infections ?\nY a-t-il un risque de crise vaso-occlusive ?\nLes problèmes hépatiques sont-ils fréquents ?\nComment surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D006444?mesh_terms=Ferric+Compounds#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hémoglobine C",
"description": "Quels sont les facteurs de risque de l'hémoglobine C ?\nL'origine ethnique influence-t-elle le risque ?\nLes antécédents familiaux sont-ils importants ?\nLe mode de vie affecte-t-il le risque ?\nLes femmes enceintes doivent-elles être testées ?",
"url": "https://questionsmedicales.fr/mesh/D006444?mesh_terms=Ferric+Compounds#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hémoglobine C ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin spécifique, comme l'électrophorèse de l'hémoglobine, permet de diagnostiquer."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'hémoglobine C ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'électrophorèse et le dosage de l'hémoglobine C dans le sang."
}
},
{
"@type": "Question",
"name": "L'hémoglobine C est-elle héréditaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hémoglobine C est une condition génétique transmise par les parents."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un test pour l'hémoglobine C ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'anémie ou des douleurs abdominales peuvent justifier un test."
}
},
{
"@type": "Question",
"name": "Peut-on détecter l'hémoglobine C à la naissance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage néonatal peut inclure des tests pour l'hémoglobine C."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hémoglobine C ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, jaunisse, et douleurs osseuses ou abdominales."
}
},
{
"@type": "Question",
"name": "L'hémoglobine C cause-t-elle de l'anémie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hémoglobine C peut entraîner une anémie due à la destruction des globules rouges."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications liées à l'hémoglobine C ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des crises douloureuses et des infections fréquentes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les enfants et les jeunes adultes."
}
},
{
"@type": "Question",
"name": "L'hémoglobine C provoque-t-elle des douleurs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir en raison de la vaso-occlusion des vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'hémoglobine C ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Étant génétique, l'hémoglobine C ne peut pas être prévenue, mais des conseils génétiques aident."
}
},
{
"@type": "Question",
"name": "Le dépistage est-il recommandé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage est recommandé pour les personnes à risque, notamment les porteurs."
}
},
{
"@type": "Question",
"name": "Comment éviter les complications ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hydratation et des soins médicaux réguliers aident à éviter les complications."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques sont-ils utiles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conseils génétiques aident les familles à comprendre les risques de transmission."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccinations recommandées ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vaccinations contre certaines infections sont recommandées pour les patients."
}
},
{
"@type": "Question",
"name": "Comment traite-t-on l'hémoglobine C ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des transfusions sanguines et des médicaments pour l'anémie."
}
},
{
"@type": "Question",
"name": "Les transfusions sont-elles nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des transfusions peuvent être nécessaires en cas d'anémie sévère ou de complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques pour l'hémoglobine C ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme l'hydroxyurée peuvent être prescrits pour réduire les crises."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore une option standard pour l'hémoglobine C."
}
},
{
"@type": "Question",
"name": "Comment gérer les crises douloureuses ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques et une hydratation adéquate aident à gérer les crises douloureuses."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des crises douloureuses et des problèmes hépatiques."
}
},
{
"@type": "Question",
"name": "L'hémoglobine C augmente-t-elle le risque d'infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients ont un risque accru d'infections en raison de l'anémie et de la splénomégalie."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de crise vaso-occlusive ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les crises vaso-occlusives peuvent survenir, provoquant des douleurs intenses."
}
},
{
"@type": "Question",
"name": "Les problèmes hépatiques sont-ils fréquents ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes hépatiques peuvent survenir, surtout en cas de transfusions fréquentes."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des bilans sanguins aident à surveiller les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hémoglobine C ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux et l'origine ethnique, notamment africaine."
}
},
{
"@type": "Question",
"name": "L'origine ethnique influence-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes d'origine africaine ou méditerranéenne sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des membres de la famille atteints augmente le risque de développer l'hémoglobine C."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire les complications, mais ne prévient pas la condition."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être testées ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage est recommandé pour les femmes enceintes à risque d'hémoglobine C."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
1Physical Chemistry of Biosystems, Heidelberg University, Im Neuenheimer Feld 253, 69120 Heidelberg, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
3Department of Infectious Diseases, Parasitology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
3Department of Infectious Diseases, Parasitology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
1Physical Chemistry of Biosystems, Heidelberg University, Im Neuenheimer Feld 253, 69120 Heidelberg, Germany.
7Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501 Japan.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Institute of Medical Microbiology and Hygiene, Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Institute of Medical Microbiology and Hygiene, Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Core Facility for Functional Peptidomics, Ulm Peptide Pharmaceuticals (U-PEP), Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Core Facility for Functional Peptidomics, Ulm Peptide Pharmaceuticals (U-PEP), Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Core Unit of Mass Spectrometry and Proteomics, Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Computational Biochemistry, Center of Medical Biotechnology, University of Duisburg-Essen, 45141, Essen, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Max-Planck-Institute for Polymer Research Mainz, 55128, Mainz, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Institute of Medical Microbiology and Hygiene, Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Central Facility for Electron Microscopy, Ulm University, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Institute of Medical Microbiology and Hygiene, Ulm University Medical Center, 89081, Ulm, Germany.
Publications dans "Hémoglobine C" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany. jan.muench@uni-ulm.de.
Core Unit of Mass Spectrometry and Proteomics, Ulm University Medical Center, 89081, Ulm, Germany. jan.muench@uni-ulm.de.
Publications dans "Hémoglobine C" :
The intravenous iron formulations ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) offer the possibility of administering a large amount of iron in one infusion. This results in faster corre...
Ferric carboxymaltose therapy reduces symptoms and improves quality of life in patients who have heart failure with a reduced ejection fraction and iron deficiency. Additional evidence about the effec...
In this double-blind, randomized trial, we assigned ambulatory patients with heart failure, a left ventricular ejection fraction of 40% or less, and iron deficiency, in a 1:1 ratio, to receive intrave...
We enrolled 3065 patients, of whom 1532 were randomly assigned to the ferric carboxymaltose group and 1533 to the placebo group. Death by month 12 occurred in 131 patients (8.6%) in the ferric carboxy...
Among ambulatory patients who had heart failure with a reduced ejection fraction and iron deficiency, there was no apparent difference between ferric carboxymaltose and placebo with respect to the hie...
Co-extrusion of ferric pyrophosphate (FePP) with solubilizers, citric acid/trisodium citrate (CA/TSC), or ethylenediaminetetraacetic acid (EDTA) sharply increases iron absorption. Whether this can pro...
Our objectives were to 1) investigate the ligand coordination of iron, zinc, and solubilizers in extruded rice and test associations with iron solubility and absorption, 2) assess whether co-extrusion...
We produced labeled...
The addition of zinc and solubilizers created new iron coordination complexes of Fe(III) species with a weak ligand field at a high-spin state that correlated with solubility (r...
Rice extrusion of FePP with solubilizers resulted in bioavailable iron coordination complexes. In the case of FePP + CA/TSC, PA exerted similar inhibition of FIA as with FeSO...
Intravenous (IV) iron is the preferred treatment for patients with iron deficiency anemia (IDA) who require rapid replenishment of iron stores or in whom oral iron is not tolerated or effective. Data ...
RCTs reporting the incidence of blindly adjudicated cardiovascular events in IDA patients treated with IV iron were identified by systematic literature review (SLR). Pairwise random effects meta-analy...
The SLR retrieved 694 unique articles, of which four were RCTs reporting the incidence of the composite cardiovascular endpoint; two studies comparing FCM (N = 1529) with IS (N = 1505), and two studie...
Pooling data from four large-scale RCTs suggested that FDI was associated with significantly lower incidence of cardiovascular adverse events compared to both FCM and IS....
A multicenter, randomized, open-label, phase III study was conducted to compare the efficacy and safety of intravenous ferric derisomaltose (FDI) versus saccharated ferric oxide (SFO) in Japanese pati...
Bioremediation provides an environmentally sound solution for hydrocarbon removal. Although bioremediation under anoxic conditions is slow, it can be coupled with methanogenesis and is suitable for en...
The randomized IronIC trial evaluated the effect of intravenous ferric derisomaltose on physical capacity in iron-deficient, maintenance heart transplant (HTx) recipients. Iron deficiency was defined ...
We assessed key governors of iron homeostasis, such as hepcidin, soluble transferrin receptor (sTfR), and interleukin-6 (IL-6). We also measured growth factors and inflammatory markers with relevance ...
Hepcidin did not differ between HTx recipients and controls, even though markers of inflammation were modestly elevated. However, HTx recipients with ferritin <30 μg/L or sTfR above the reference rang...
HTx recipients with iron deficiency as defined in heart failure do not have elevated hepcidin levels, although inflammatory markers are modestly increased. The high ferritin cut-offs used in heart fai...
In this study, a fast, reproducible and simple-to-apply a new potentiometric determination method was developed for the evaluation of iron (III) reducing power (FRAP), one of the antioxidant capacity ...
The heterogeneous Fenton-like reaction (HeFR) has always been a research focus for environmental applications. However, it has long been difficult to reach a consensus on the reaction mechanism becaus...
Cardiovascular diseases are a leading cause of mortality and morbidity worldwide. Aberrant thrombosis is a common feature of systemic conditions like diabetes and obesity, and chronic inflammatory dis...